Silhouette represents a new class of synthetic biomaterials that aims to provide optimized intraoperative handling and biologic responsiveness at the defect site. The bone graft comprises a clinically proven bi-phasic mineral component suspended within a woven network of type I collagen fibers. It is tailored to support bone bonding and sustained remodeling during healing process.
More articles on devices:
TissueGen to expand spinal cord injury repair program — 5 key updates
K2M’s MESA 2 Deformity Spinal System receives FDA 510(k) clearance
Dr. John Peloza performs 1st U.S. surgery using FLXfit 3D expandable interbody cage
